Synapse - Works

Results (115370)

Urologists’ perceptions and behaviors related to tobacco use

Meeting Abstract

Matulewicz, R.
Tobacco Prevention and Cessation (2023)

Session on tobacco and e-cigarette use and urological cancers: Major conclusions on the risk, beliefs and behaviors, preventive recommendations

Meeting Abstract

Przewoźniak, K.; Nolazco, J.; Bjurlin, M.; Matulewicz, R.; Daly, J.; Soria, F.
Tobacco Prevention and Cessation (2023)

Fulltext@MSK | Save

Характеристика и управление нежелательными реакциями у пациентов с распространенным раком эндометрия, которые получают комбинацию ленватиниб плюс пембролизумаб

Journal Article

Colombo, N.; Lorusso, D.; Monk, B. J.; Slomovitz, B.; Hasegawa, K.; Nogueira-Rodrigues, A.; Zale, M.; Okpara, C. E.; Barresi, G.; McKenzie, J.; more...
Clinical Review for General Practice (2023)

Fulltext@MSK | Save

Comparative effectiveness of teclistamab versus real-world physician's choice of therapy (RWPC) for patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Krishnan, A.; Nooka, A.; Chari, A.; Garfall, A. L.; Martin, T.; Nair, S.; Lin, X.; Qi, K.; Londhe, A.; Pei, L.; more...
Value in Health (2023)

Fulltext@MSK | Save

An updated cost-effectiveness analysis of axicabtagene ciloleucel in second-line large B-cell lymphoma patients in the United States

Meeting Abstract

Oluwole, O.; Patel, A.; Vadgama, S.; Smith, N.; Blissett, R. S.; Feng, C.; Dickinson, M.; Johnston, P.; Perales, M. A.
Value in Health (2023)

Fulltext@MSK | Save

Matching-adjusted indirect treatment comparison (MAIC) of teclistamab versus selinexor-dexamethasone for the treatment of patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Moreau, P.; Usmani, S. Z.; van de Donk, N. W. C. J.; Garfall, A. L.; Delforge, M.; Oriol, A.; Nooka, A.; Rosiñol, L.; Bahlis, N.; Rodriguez Otero, P.; more...
Value in Health (2023)

Fulltext@MSK | Save

Matching-adjusted indirect treatment comparison (MAIC) of teclistamab vs belantamab mafodotin for the treatment of patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Moreau, P.; Usmani, S. Z.; van de Donk, N. W. C. J.; Garfall, A. L.; Delforge, M.; Oriol, A.; Nooka, A.; Rosiñol, L.; Bahlis, N.; Otero, P. R.; more...
Value in Health (2023)

Fulltext@MSK | Save

Adjusted comparison of teclistamab versus real-world physician's choice (RWPC) of therapy in patients with triple-class exposed (TCE) relapsed/refractory multiple myeloma (RRMM)

Meeting Abstract

Mateos, M. V.; Chari, A.; Usmani, S. Z.; Goldschmidt, H.; Weisel, K.; Qi, K.; Londhe, A.; Nair, S.; Lin, X.; Pei, L.; more...
Value in Health (2023)

Fulltext@MSK | Save

Teaching professional ethics in medical physics graduate program

Meeting Abstract

Popovic, M.; Levesque, I. R.; Stambaugh, C.; Wang, D.
Radiotherapy and Oncology (2023)

Fulltext@MSK | Save

GBM agile platform trial for newly diagnosed and recurrent GBM: Results of first experimental arm, regorafenib

Meeting Abstract

Wen, P.; Alexander, B.; Berry, D.; Buxton, M.; Cavenee, W.; Colman, H.; de Groot, J.; Ellingson, B.; Gordon, G.; Hyddmark, E.; more...
Neuro-Oncology (2023)

Fulltext@MSK | Save